ArticleBriefings in bioinformatics2026
Celebrating 25 years of briefings in bioinformatics: a comprehensive bibliometric analysis.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past 25 years, Briefings in Bioinformatics (BIB) has been the leading journal in the bioinformatics field. To commemorate this milestone and trace the journal's academic trajectory, we conducted a comprehensive bibliometric analysis of 4185 BIB publications published between 2000 and 2024. The publications were retrieved from Elsevier's Scopus. Since 2021, the annual number of citations has increased prominently, peaking in 2024 (n = 30 729). These publications have accumulated a total of 183 911 citations, including 364 publications that have received more than 100 citations. The most cited article was published by Kumar et al. (2004) and it has received 10 750 citations. The 4185 publications were contributed by 4140 authors from 79 countries/regions, reflecting BIB's international characteristics. In terms of the total number of publications (TP) and the total number of citations (TC), China (TP = 2085; TC = 58 851), the United States (TP = 1120; TC = 67 000), and the United Kingdom (TP = 329; TC = 16 581) were the leading countries. The Chinese Academy of Sciences (TP = 216; TC = 6200), Central South University (TP = 112; TC = 3079), and Zhejiang University (TP = 105; TC = 3503) were the leading affiliations. Zou, Quan (TP = 64; TC = 3023), Song, Jiangning (TP = 58; TC = 2652), and Wu, Rongling (TP = 35; TC = 633) were the leading authors. Collaboration has intensified over time, with the median number of authors per publication rising from two in 2000-2004 to five in 2020-2024. The research focus of BIB has shifted from foundational bioinformatics and database development to integrative multi-omics analysis and AI-driven biomedical research. As BIB develops, its international impact will continue to grow, solidifying its pivotal role in shaping the future of bioinformatics research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.